AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update
March 14, 2024 07:00 ET
|
AC Immune SA
AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update ACI-24.060 ABATE Phase 2 trial to report Abeta-PET imaging results in Q2 and H2ACI-7104.056 VacSYn Phase 2 trial in...
AC Immune Announces Upcoming Presentations at AD/PD™ 2024
February 22, 2024 07:00 ET
|
AC Immune SA
AC Immune Announces Upcoming Presentations at AD/PD™ 2024 Multiple presentations at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™ 2024)Andrea Pfeifer, Ph.D., CEO to...
AC Immune Progress Update on Phase 2 Active Immunotherapy Clinical Pipeline for Alzheimer's and Parkinson diseases
January 03, 2024 08:10 ET
|
AC Immune SA
AC Immune Progress Update on Phase 2 Active Immunotherapy Clinical Pipeline for Alzheimer's and Parkinson diseases ABATE Phase 1b/2 AD trial of ACI-24.060 completed enrollment of cohorts 1 and 2 and...
NRG Therapeutics Awarded Second $500K Grant from The Michael J. Fox Foundation to Further Progress Parkinson’s Programme
February 22, 2023 04:00 ET
|
NRG Therapeutics Limited
STEVENAGE, United Kingdom, Feb. 22, 2023 (GLOBE NEWSWIRE) -- NRG Therapeutics, Ltd., an innovative neuroscience company targeting mitochondrial dysfunction, is pleased to announce that it has been...
IGC to Present at the RHK 2022 Disruptive Growth Conference
November 30, 2022 11:19 ET
|
INDIA GLOBALIZATION CAPITAL INC.
POTOMAC, Md., Nov. 30, 2022 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc (NYSE American: IGC) (“IGC” or the “Company”) today announced that Ram Mukunda, Chief Executive Officer, will be...
IMAC Holdings to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference
January 05, 2021 09:00 ET
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn., Jan. 05, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative...
CORRECTING and REPLACING – Jeff Robinson, CEO of Wuhan, Provides Key Updates and Outlook in a New Audio Interview with SmallCapVoice.com
May 22, 2020 10:43 ET
|
Wuhan General Group, Inc.
AUSTIN, Texas, May 22, 2020 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by SmallCapVoice.com, Inc. and Wuhan General Group, Inc. (OTC PINK: WUHN), please note that...
Jeff Robinson, CEO of Wuhan, Provides Key Updates and Outlook in a New Audio Interview with SmallCapVoice.com
May 22, 2020 08:00 ET
|
Wuhan General Group, Inc.
AUSTIN, Texas, May 22, 2020 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. (SCV) and Wuhan General Group, Inc. (OTC PINK: WUHN) (the "Company" and "Wuhan"), announced today that a new audio interview...
Naboso™ Technology Expands Product Line to include the First Commercially Available Textured Insoles and Mats designed to Improve Posture, Balance and Strength through Stimulation of the Feet
January 22, 2019 09:00 ET
|
Naboso Technology
NEW YORK, Jan. 22, 2019 (GLOBE NEWSWIRE) -- Naboso™ Technology, a leading proprioceptive insole and mat company dedicated to revolutionizing the neurological rehabilitation, human performance and...
CES: Smart Footwear brand Digitsole in partnership with the company Zhor-Tech revolutionize medical diagnostics with M-Cube technology
January 09, 2019 16:34 ET
|
Zhor-Tech
Nancy , France, Jan. 09, 2019 (GLOBE NEWSWIRE) -- Digitsole, creating the future of footwear by introducing electronics and software into footwear products, is revolutionizing the medical...